tirzepatide nash phase 3 Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2 Tirzepatide: A Game-Changer for MASH

GLP-1 medications can be used with other diabetes medicines, but there are special risks to consider: When GLP-1 medications are combined with insulin or medicines called sulfonylureas or meglitinides (which also lower blood sugar), the risk of low blood sugar (hypoglycemia) is higher

The FDA prescribing information cautions against use in patients with severe gastrointestinal disease, including severe gastroparesis

The convention defers at least two weeks after major surgery

And if you happen to be one of the 5-10% of users struggling with diarrhea or vomiting on your medication, you'll need to replenish your fluids even more rapidly